Annual Accounts Receivable
$87.86 M
-$26.97 M-23.49%
December 31, 2024
Summary
- As of February 26, 2025, TXG annual accounts receivable is $87.86 million, with the most recent change of -$26.97 million (-23.49%) on December 31, 2024.
- During the last 3 years, TXG annual accounts receivable has risen by +$2.61 million (+3.06%).
- TXG annual accounts receivable is now -23.49% below its all-time high of $114.83 million, reached on December 31, 2023.
Performance
TXG Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$87.86 M
+$4.34 M+5.19%
December 31, 2024
Summary
- As of February 26, 2025, TXG quarterly accounts receivable is $87.86 million, with the most recent change of +$4.34 million (+5.19%) on December 31, 2024.
- Over the past year, TXG quarterly accounts receivable has increased by +$4.34 million (+5.19%).
- TXG quarterly accounts receivable is now -81.72% below its all-time high of $480.74 million, reached on March 1, 2016.
Performance
TXG Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
TXG Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.5% | +5.2% |
| 3 y3 years | +3.1% | +5.2% |
| 5 y5 years | +163.3% | +5.2% |
TXG Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.5% | +3.1% | -23.5% | +15.3% |
| 5 y | 5-year | -23.5% | +163.3% | -23.5% | +286.6% |
| alltime | all time | -23.5% | +558.6% | -81.7% | +286.6% |
10x Genomics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $87.86 M(-23.5%) | $87.86 M(+5.2%) |
| Sep 2024 | - | $83.53 M(-8.4%) |
| Jun 2024 | - | $91.18 M(-0.1%) |
| Mar 2024 | - | $91.31 M(-20.5%) |
| Dec 2023 | $114.83 M(+10.2%) | $114.83 M(+10.6%) |
| Sep 2023 | - | $103.85 M(+18.4%) |
| Jun 2023 | - | $87.69 M(+12.5%) |
| Mar 2023 | - | $77.94 M(-25.2%) |
| Dec 2022 | $104.21 M(+22.2%) | $104.21 M(+24.7%) |
| Sep 2022 | - | $83.55 M(+9.6%) |
| Jun 2022 | - | $76.20 M(-0.4%) |
| Mar 2022 | - | $76.53 M(-10.2%) |
| Dec 2021 | $85.25 M(+66.5%) | $85.25 M(+8.7%) |
| Sep 2021 | - | $78.43 M(+31.4%) |
| Jun 2021 | - | $59.68 M(+4.0%) |
| Mar 2021 | - | $57.41 M(+12.1%) |
| Dec 2020 | $51.21 M | $51.21 M(+42.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $36.03 M(+58.5%) |
| Jun 2020 | - | $22.73 M(-26.3%) |
| Mar 2020 | - | $30.85 M(-7.6%) |
| Dec 2019 | $33.37 M(+18.8%) | $33.37 M(+27.6%) |
| Sep 2019 | - | $26.15 M(-2.4%) |
| Jun 2019 | - | $26.80 M(-4.6%) |
| Dec 2018 | $28.09 M(+110.5%) | $28.09 M(-94.1%) |
| Dec 2017 | $13.34 M | - |
| Sep 2017 | - | $480.03 M(+2.1%) |
| Jun 2017 | - | $470.13 M(-2.1%) |
| Mar 2017 | - | $480.17 M(+7.0%) |
| Dec 2016 | - | $448.58 M(+5.8%) |
| Sep 2016 | - | $424.00 M(-0.7%) |
| Jun 2016 | - | $427.06 M(-11.2%) |
| Mar 2016 | - | $480.74 M(+2.3%) |
| Dec 2015 | - | $470.12 M(+24.2%) |
| Sep 2015 | - | $378.41 M(-12.8%) |
| Mar 2015 | - | $433.74 M |
FAQ
- What is 10x Genomics annual accounts receivable?
- What is the all time high annual accounts receivable for 10x Genomics?
- What is 10x Genomics annual accounts receivable year-on-year change?
- What is 10x Genomics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for 10x Genomics?
- What is 10x Genomics quarterly accounts receivable year-on-year change?
What is 10x Genomics annual accounts receivable?
The current annual accounts receivable of TXG is $87.86 M
What is the all time high annual accounts receivable for 10x Genomics?
10x Genomics all-time high annual accounts receivable is $114.83 M
What is 10x Genomics annual accounts receivable year-on-year change?
Over the past year, TXG annual accounts receivable has changed by -$26.97 M (-23.49%)
What is 10x Genomics quarterly accounts receivable?
The current quarterly accounts receivable of TXG is $87.86 M
What is the all time high quarterly accounts receivable for 10x Genomics?
10x Genomics all-time high quarterly accounts receivable is $480.74 M
What is 10x Genomics quarterly accounts receivable year-on-year change?
Over the past year, TXG quarterly accounts receivable has changed by +$4.34 M (+5.19%)